passing out on semaglutide GLP-1 drugs tied to elevated risk of low blood pressure episodes SkinnyRx | Compounded Injectable Semaglutide

The most serious side effects include gastroparesis (stomach paralysis), bowel obstruction or ileus requiring surgery, intestinal blockage, gallbladder disease, vision loss including NAION (non-arteritic anterior ischemic optic neuropathy and arteritic anterior ischemic optic neuropathy), sudden vision loss or blindness, deep vein thrombosis (blood clots), severe malnutrition, and organ damage from prolonged gastrointestinal injuries

February 20, 2025: The Food and Drug Administration updates the Ozempic label

Zepbound (tirzepatide) begins at 2.5 mg weekly, with monthly increases to a maintenance dose of 5, 10, or 15 mg

doi:10.1016/j.eclinm.2024.102624 Palermo A, DOnofrio L, Eastell R, Schwartz AV, Pozzilli P, Napoli N